Transaction Details

  • Type of Transaction: Inter se transfer among Promoter and Promoter Group
  • Transaction Mode: Off-market transaction
  • Transaction Date: June 09, 2026
  • Shares Transferred: 60,842 equity shares
  • Transferor: Nectar Biopharma Private Limited (Promoter Group member)
  • Transferee: Mr. Saurabh Goyal (Promoter of the Company)
  • Consideration: Disclosed as "for consideration" but amount not specified

Shareholding Impact Analysis

The transaction results in a re-alignment of shareholding within the Promoter and Promoter Group with no change in aggregate holding:

Pre-Transaction Shareholding:

  • Saurabh Goyal (Promoter): 32,17,214 shares (33.72%)
  • Aryan Goyal (Promoter Group): 11,59,185 shares (12.15%)
  • Smita Goyal (Promoter Group): 7 shares (0.00%)

Post-Transaction Shareholding:

  • Saurabh Goyal (Promoter): 32,78,056 shares (34.35%) - Increase of 60,842 shares
  • Aryan Goyal (Promoter Group): 11,59,185 shares (12.15%) - No change
  • Smita Goyal (Promoter Group): 7 shares (0.00%) - No change

Key Implications

  • Aggregate Promoter Holding: No change - total promoter and promoter group holding remains unchanged
  • Capital Structure Impact: No dilution or consolidation effect
  • Voting Pattern: Realignment within existing promoter group without external impact
  • Financial Impact: Not quantified in the disclosure